Akèy › Psoryaz › Texas › Houston
Etid klinik pou Psoryaz nan Houston, TX
3 etid pou Psoryaz ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- UT MD Anderson Cancer Center, Houston
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- Center for Clinical Studies, Houston
- Bellaire Dermatology Associates, Bellaire · 7 mi lwen
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Ap rekriteEtid obsèvasyon
- M D Anderson Cancer Center, Houston
Etid Psoryaz nan lòt vil
- Trenton, NJ7 etid
- Newton, MA6 etid
- Cleveland, OH6 etid
- New York City, NY5 etid
- San Antonio, TX5 etid
- Fremont, CA5 etid
- Philadelphia, PA5 etid
- Miami, FL4 etid
- Huntington Beach, CA4 etid
- Birmingham, AL4 etid
- Rochester, NY3 etid
- Indianapolis, IN3 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè90 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas62 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.